Moderna pushes for COVID-19 vaccine boosters in older adults,
© Reuters. FILE PHOTO: Syringes filled with a dose of the Moderna COVID-19 vaccine sit on a table during an employee vaccination at the Sarasota Memorial Hospital in Sarasota, Florida, U.S., September 24, 2021. REUTERS/Shannon Stapleton
(Reuters) -Moderna Inc on Tuesday said the U.S. Food and Drug Administration should authorize booster doses of its COVID-19 vaccine in fully vaccinated older adults and high-risk individuals.
The company said its data supports the public health benefit of a booster dose of its vaccine to restore immune response, while reducing the number of “breakthrough” infections in fully-vaccinated adults.
Moderna (NASDAQ:)’s comments were released in briefing documents ahead of a Thursday and Friday meeting of the FDA’s outside expert advisers to discuss booster doses of Moderna and Johnson & Johnson (NYSE:)’s COVID-19 vaccines.
Rival Johnson & Johnson on Tuesday also cited data showing increased protection after a booster dose, which it said could be either administered as early as two months after the original dose of its vaccine.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Read More: Moderna pushes for COVID-19 vaccine boosters in older adults,